Bio Elpida
Development services and manufacturing innovative therapies.
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenues | 2.7m | 2.1m | 2.1m | 2.3m | 2.1m | 2.1m | 3.0m |
| % growth | - | (22 %) | (2 %) | 11 % | (8 %) | (3 %) | 48 % |
| EBITDA | <1m | (<1m) | (<1m) | (<1m) | (<1m) | (1.1m) | (1.5m) |
| % EBITDA margin | 18 % | (4 %) | (14 %) | (11 %) | (39 %) | (53 %) | (50 %) |
| Profit | <1m | <1m | (<1m) | <1m | (<1m) | (<1m) | <1m |
| % profit margin | 27 % | 6 % | (5 %) | - | (34 %) | (18 %) | 1 % |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Acquisition | |
| Total Funding | - | ||
Recent News about Bio Elpida
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.